Close
ACHEMA MIDDLE EAST 2026

Swiss Pharma Sector In EU Negotiations- Stakes Are Sky High

In a recent development, Switzerland may very well lose out as a manufacturing location if its differences with the European Union are not sorted...

Assessing Q1 2023: Indian Pharma Industry Growing Rapidly

Pharmaceutical companies are turning their attention to the Indian market as revenues decline in the US, Europe, and emerging markets. Indian companies like Sun...

2028 May See European Pharma Firms Cross US Giants In Sales

The worldwide pharmaceutical sector is going through a major overhaul that is most definitely going to shape its future. It is estimated that by...

Buyouts Dwindle As Pharma Sector Faces Pricing Concerns

The pharmaceutical industry is currently facing various challenges, including concerns about pricing due to the Inflation Reduction Act and increased scrutiny from the Federal...

Unconstitutional Price-Setting Provisions: PhRMA Asserts

NICA, PhRMA, and GCCA lodged a complaint in the U.S. District Court for the Western District of Texas, asserting that the price setting provisions...

Pharma May Lose Out To Competition Due To EU Health Package

In a major concern surrounding Europe’s pharma industry, there is an anticipation that it could go on to lose out to elevated competition from...

Pharma Trade Group Sues Biden Admin Over Medicare Drug Costs

On June 21, the pharma sector’s biggest lobbying group, along with two major organisations, went on to sue the Biden administration when it came...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...